1型糖尿病患者-话题@MedSci - 梅斯（MedSci）

#1型糖尿病患者#

188篇内容 | 3946人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1968282, encodeId=7d331968282c0, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, objectTitle=DIABETOLOGIA：胰岛素停用和随后的胰岛素治疗后1型糖尿病患者的基质代谢，激素和细胞因子水平以及脂肪组织信号传导，以模拟酮症酸中毒的起始步骤, objectType=article, longId=163579, objectId=62ae1635e9d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62ae1635e9d3, replyNumber=0, likeNumber=60, createdTime=2019-07-26, rootId=0, userName=millore, userId=c0e3195, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62ae1635e9d3, moduleTitle=DIABETOLOGIA：胰岛素停用和随后的胰岛素治疗后1型糖尿病患者的基质代谢，激素和细胞因子水平以及脂肪组织信号传导，以模拟酮症酸中毒的起始步骤, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=62ae1635e9d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968294, encodeId=67e8196829415, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, objectTitle=JCEM：1型糖尿病患者骨矿物质密度, objectType=article, longId=182310, objectId=7539182310fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7539182310fd, replyNumber=0, likeNumber=92, createdTime=2020-09-08, rootId=0, userName=millore, userId=c0e3195, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7539182310fd, moduleTitle=JCEM：1型糖尿病患者骨矿物质密度, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7539182310fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968295, encodeId=3eba196829595, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, objectTitle=FDA批准用于1型糖尿病患者的新型闭环胰岛素输送系统, objectType=article, longId=184821, objectId=f3a1184821ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3a1184821ac, replyNumber=0, likeNumber=65, createdTime=2019-12-29, rootId=0, userName=millore, userId=c0e3195, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3a1184821ac, moduleTitle=FDA批准用于1型糖尿病患者的新型闭环胰岛素输送系统, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f3a1184821ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968281, encodeId=d8f3196828173, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, objectTitle=Diabetes Care：尿酸是1型糖尿病患者肾功能、心血管事件和死亡率的独立危险因素, objectType=article, longId=163528, objectId=690016352877, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=690016352877, replyNumber=0, likeNumber=77, createdTime=2019-12-06, rootId=0, userName=millore, userId=c0e3195, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=690016352877, moduleTitle=Diabetes Care：尿酸是1型糖尿病患者肾功能、心血管事件和死亡率的独立危险因素, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=690016352877)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968280, encodeId=dbbb1968280fe, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, objectTitle=Diabetic Med：评估甘精胰岛素300单位/ ml在常规治疗1型糖尿病患者的临床实践中有效性（SPARTA）, objectType=article, longId=163436, objectId=4bb81634363b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bb81634363b, replyNumber=0, likeNumber=48, createdTime=2019-06-21, rootId=0, userName=millore, userId=c0e3195, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bb81634363b, moduleTitle=Diabetic Med：评估甘精胰岛素300单位/ ml在常规治疗1型糖尿病患者的临床实践中有效性（SPARTA）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4bb81634363b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968293, encodeId=ce49196829388, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, objectTitle=Diabetes Care：1型糖尿病患者严重低血糖和酮症酸中毒发病率和微血管并发症患病率, objectType=article, longId=180001, objectId=062c18000179, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=062c18000179, replyNumber=0, likeNumber=77, createdTime=2020-05-05, rootId=0, userName=millore, userId=c0e3195, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=062c18000179, moduleTitle=Diabetes Care：1型糖尿病患者严重低血糖和酮症酸中毒发病率和微血管并发症患病率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=062c18000179)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968288, encodeId=99801968288eb, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, objectTitle=Diabetes Care：1型糖尿病患者房颤的危险因素, objectType=article, longId=167878, objectId=170c16e8781b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=170c16e8781b, replyNumber=0, likeNumber=73, createdTime=2019-11-05, rootId=0, userName=millore, userId=c0e3195, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=170c16e8781b, moduleTitle=Diabetes Care：1型糖尿病患者房颤的危险因素, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=170c16e8781b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968277, encodeId=156319682e799, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, objectTitle=2019 国际共识：接受SGLT抑制剂治疗的1型糖尿病患者糖尿病酸中毒风险管理, objectType=article, longId=160685, objectId=e214160685ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e214160685ac, replyNumber=0, likeNumber=36, createdTime=2019-07-30, rootId=0, userName=millore, userId=c0e3195, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e214160685ac, moduleTitle=2019 国际共识：接受SGLT抑制剂治疗的1型糖尿病患者糖尿病酸中毒风险管理, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e214160685ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968278, encodeId=96c819682e881, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, objectTitle=JCEM：1型糖尿病患者心血管自主神经功能障碍与外周动脉硬化的关系, objectType=article, longId=161498, objectId=7fe216149877, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fe216149877, replyNumber=0, likeNumber=72, createdTime=2019-04-06, rootId=0, userName=millore, userId=c0e3195, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fe216149877, moduleTitle=JCEM：1型糖尿病患者心血管自主神经功能障碍与外周动脉硬化的关系, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7fe216149877)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968279, encodeId=282519682e901, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, objectTitle=Diabetic Med：1型糖尿病患者的无症状性低血糖：发病率和危险因素, objectType=article, longId=163005, objectId=bd40163005c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd40163005c3, replyNumber=0, likeNumber=74, createdTime=2020-01-18, rootId=0, userName=millore, userId=c0e3195, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd40163005c3, moduleTitle=Diabetic Med：1型糖尿病患者的无症状性低血糖：发病率和危险因素, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bd40163005c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968292, encodeId=350d196829225, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, objectTitle=Circulation：二甲双胍改善青少年1型糖尿病患者胰岛素抵抗及心血管功能, objectType=article, longId=177921, objectId=2d3f1e792112, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d3f1e792112, replyNumber=0, likeNumber=60, createdTime=2020-03-08, rootId=0, userName=millore, userId=c0e3195, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d3f1e792112, moduleTitle=Circulation：二甲双胍改善青少年1型糖尿病患者胰岛素抵抗及心血管功能, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2d3f1e792112)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968290, encodeId=2e19196829062, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, objectTitle=Diabetes Care：1型糖尿病患者很低冠状动脉疾病风险的更佳血压阈值, objectType=article, longId=174663, objectId=27771e466347, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27771e466347, replyNumber=0, likeNumber=85, createdTime=2019-07-30, rootId=0, userName=millore, userId=c0e3195, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27771e466347, moduleTitle=Diabetes Care：1型糖尿病患者很低冠状动脉疾病风险的更佳血压阈值, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=27771e466347)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968286, encodeId=c1ba1968286f2, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, objectTitle=Diabetic Med：晚期糖基化终产物在皮肤中的积累与1型糖尿病患者的胰岛素抵抗有关, objectType=article, longId=165694, objectId=d55f1656943a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d55f1656943a, replyNumber=0, likeNumber=52, createdTime=2019-05-12, rootId=0, userName=millore, userId=c0e3195, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d55f1656943a, moduleTitle=Diabetic Med：晚期糖基化终产物在皮肤中的积累与1型糖尿病患者的胰岛素抵抗有关, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d55f1656943a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968267, encodeId=bf1f196826e2e, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, objectTitle=Diabetic Med：根据糖尿病诊断年龄，非洲裔美国人和美国白人1型糖尿病患者的成年后期死亡率, objectType=article, longId=152244, objectId=53a915224465, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53a915224465, replyNumber=0, likeNumber=63, createdTime=2019-06-20, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53a915224465, moduleTitle=Diabetic Med：根据糖尿病诊断年龄，非洲裔美国人和美国白人1型糖尿病患者的成年后期死亡率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=53a915224465)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968272, encodeId=d99d19682e205, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, objectTitle=DIABETOLOGIA：吸烟对1型糖尿病患者冠心病，心力衰竭和中风风险的剂量依赖性影响如何？, objectType=article, longId=155004, objectId=5f30155004b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f30155004b5, replyNumber=0, likeNumber=64, createdTime=2019-02-27, rootId=0, userName=millore, userId=c0e3195, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f30155004b5, moduleTitle=DIABETOLOGIA：吸烟对1型糖尿病患者冠心病，心力衰竭和中风风险的剂量依赖性影响如何？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5f30155004b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968261, encodeId=6ee7196826151, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, objectTitle=Neurology：创伤性脑损伤与1型糖尿病患者痴呆风险相关, objectType=article, longId=150237, objectId=f00215023e85, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f00215023e85, replyNumber=0, likeNumber=113, createdTime=2019-05-02, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f00215023e85, moduleTitle=Neurology：创伤性脑损伤与1型糖尿病患者痴呆风险相关, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f00215023e85)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968268, encodeId=64d2196826857, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, objectTitle=【病例分享】渴络欣胶囊治疗1型糖尿病患者慢性肾脏病1例, objectType=article, longId=152291, objectId=1fae152291da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fae152291da, replyNumber=0, likeNumber=92, createdTime=2019-09-30, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fae152291da, moduleTitle=【病例分享】渴络欣胶囊治疗1型糖尿病患者慢性肾脏病1例, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1fae152291da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968266, encodeId=08d7196826607, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, objectTitle=Diabetic Med：北京和汕头1型糖尿病患者的年龄分布和代谢紊乱状况如何？, objectType=article, longId=152242, objectId=f4ee15224236, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4ee15224236, replyNumber=0, likeNumber=78, createdTime=2019-03-23, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4ee15224236, moduleTitle=Diabetic Med：北京和汕头1型糖尿病患者的年龄分布和代谢紊乱状况如何？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f4ee15224236)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968283, encodeId=f122196828310, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, objectTitle=Diabetes Care：1型糖尿病患者BMI、死亡率和心血管结局, objectType=article, longId=165403, objectId=fcfa1654031c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcfa1654031c, replyNumber=0, likeNumber=61, createdTime=2020-02-18, rootId=0, userName=millore, userId=c0e3195, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcfa1654031c, moduleTitle=Diabetes Care：1型糖尿病患者BMI、死亡率和心血管结局, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fcfa1654031c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968289, encodeId=4610196828935, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, objectTitle=JAHA：年青1型糖尿病患者的心血管危险因素和动脉僵化负担, objectType=article, longId=168923, objectId=3a0d168923c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a0d168923c9, replyNumber=0, likeNumber=0, createdTime=2020-06-05, rootId=0, userName=millore, userId=c0e3195, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a0d168923c9, moduleTitle=JAHA：年青1型糖尿病患者的心血管危险因素和动脉僵化负担, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3a0d168923c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

1型糖尿病患者

2020-05-29

millore (审核中...)

前往app查看评论内容

#1型糖尿病患者#

DIABETOLOGIA：胰岛素停用和随后的胰岛素治疗后1型糖尿病患者的基质代谢，激素和细胞因子水平以及脂肪组织信号传导，以模拟酮症酸中毒的起始步骤

2019-07-26

millore (审核中...)

前往app查看评论内容

#1型糖尿病患者#

JCEM：1型糖尿病患者骨矿物质密度

2020-09-08

millore (审核中...)

前往app查看评论内容

#1型糖尿病患者#

FDA批准用于1型糖尿病患者的新型闭环胰岛素输送系统

2019-12-29

millore (审核中...)

前往app查看评论内容

#1型糖尿病患者#

Diabetes Care：尿酸是1型糖尿病患者肾功能、心血管事件和死亡率的独立危险因素

2019-12-06

millore (审核中...)

前往app查看评论内容

#1型糖尿病患者#

Diabetic Med：评估甘精胰岛素300单位/ ml在常规治疗1型糖尿病患者的临床实践中有效性（SPARTA）

2019-06-21

millore (审核中...)

前往app查看评论内容

#1型糖尿病患者#

Diabetes Care：1型糖尿病患者严重低血糖和酮症酸中毒发病率和微血管并发症患病率

2020-05-05

millore (审核中...)

前往app查看评论内容

#1型糖尿病患者#

Diabetes Care：1型糖尿病患者房颤的危险因素

2019-11-05

millore (审核中...)

前往app查看评论内容

#1型糖尿病患者#

2019 国际共识：接受SGLT抑制剂治疗的1型糖尿病患者糖尿病酸中毒风险管理

2019-07-30

millore (审核中...)

前往app查看评论内容

#1型糖尿病患者#

JCEM：1型糖尿病患者心血管自主神经功能障碍与外周动脉硬化的关系

2019-04-06

millore (审核中...)

前往app查看评论内容

#1型糖尿病患者#

Diabetic Med：1型糖尿病患者的无症状性低血糖：发病率和危险因素

2020-01-18

millore (审核中...)

前往app查看评论内容

#1型糖尿病患者#

Circulation：二甲双胍改善青少年1型糖尿病患者胰岛素抵抗及心血管功能

2020-03-08

millore (审核中...)

前往app查看评论内容

#1型糖尿病患者#

Diabetes Care：1型糖尿病患者很低冠状动脉疾病风险的更佳血压阈值

2019-07-30

millore (审核中...)

前往app查看评论内容

#1型糖尿病患者#

Diabetic Med：晚期糖基化终产物在皮肤中的积累与1型糖尿病患者的胰岛素抵抗有关

2019-05-12

一叶知秋 (审核中...)

前往app查看评论内容

#1型糖尿病患者#

Diabetic Med：根据糖尿病诊断年龄，非洲裔美国人和美国白人1型糖尿病患者的成年后期死亡率

2019-06-20

millore (审核中...)

前往app查看评论内容

#1型糖尿病患者#

DIABETOLOGIA：吸烟对1型糖尿病患者冠心病，心力衰竭和中风风险的剂量依赖性影响如何？

2019-02-27

一叶知秋 (审核中...)

前往app查看评论内容

#1型糖尿病患者#

Neurology：创伤性脑损伤与1型糖尿病患者痴呆风险相关

2019-05-02

一叶知秋 (审核中...)

前往app查看评论内容

#1型糖尿病患者#

【病例分享】渴络欣胶囊治疗1型糖尿病患者慢性肾脏病1例

2019-09-30

一叶知秋 (审核中...)

前往app查看评论内容

#1型糖尿病患者#

Diabetic Med：北京和汕头1型糖尿病患者的年龄分布和代谢紊乱状况如何？

2019-03-23

millore (审核中...)

前往app查看评论内容

#1型糖尿病患者#

Diabetes Care：1型糖尿病患者BMI、死亡率和心血管结局

2020-02-18

millore (审核中...)

前往app查看评论内容

#1型糖尿病患者#

JAHA：年青1型糖尿病患者的心血管危险因素和动脉僵化负担

2020-06-05

科室
- - 订阅+
  - 更多科室
工具
服务